Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)

China flag China · Delayed Price · Currency is CNY
15.24
0.00 (0.00%)
At close: Dec 12, 2025
-20.83%
Market Cap17.02B
Revenue (ttm)2.70B
Net Income (ttm)-100.29M
Shares Out1.12B
EPS (ttm)-0.08
PE Ration/a
Forward PE72.85
Dividend0.09 (0.59%)
Ex-Dividend DateJun 6, 2025
Volume7,708,575
Average Volume9,325,827
Open15.27
Previous Close15.24
Day's Range15.15 - 15.35
52-Week Range13.10 - 21.12
Beta1.10
RSI26.98
Earnings DateApr 21, 2026

About SHE:300601

Shenzhen Kangtai Biological Products Co., Ltd. researches and develops, produces, and sells various types of human vaccines in China. The company’s marketed vaccines include 13-valent pneumococcal polysaccharide conjugate vaccine, varicella vaccine, freeze-dried, hepatitis B vaccine, inflammatory vaccine, 23-valent pneumococcal polysaccharide vaccine, DTAP/HIB combined vaccine, diphtheria, tetanus and acellular pertussis combined vaccine, adsorbed, rabies vaccine (human diploid cell) for human use, hib conjugate vaccine, measles and rubella com... [Read more]

Sector Healthcare
Founded 1992
Employees 1,913
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300601
Full Company Profile

Financial Performance

In 2024, SHE:300601's revenue was 2.65 billion, a decrease of -23.75% compared to the previous year's 3.48 billion. Earnings were 201.65 million, a decrease of -76.59%.

Financial Statements

News

There is no news available yet.